Fidson Healthcare Plc (NGX: FIDSON)

Market Cap	32.13B
Revenue (ttm)	72.41B
Net Income (ttm)	3.48B
Shares Out	2.29B
EPS (ttm)	1.51
PE Ratio	9.25
Forward PE	n/a
Dividend	0.60 (4.29%)
Ex-Dividend Date	n/a

Volume	903,174
Open	14.00
Previous Close	14.50
Day's Range	14.00 - 14.00
52-Week Range	12.40 - 19.20
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 28, 2025

About Fidson Healthcare

Fidson Healthcare Plc manufactures and distributes pharmaceutical products in Nigeria. The company operates in three segments: Over-the-Counter, Ethical Products, and Consumer Healthcare Product. It offers drugs, infusions, and injectables. The company also provides products for anti infective and anti malaria, central nervous system, and cough and cold, gastrointestinal medicines; supplements; topical/dermatological medicines; vitamins and minerals; and ophthalmic solutions. Fidson Healthcare Plc was incorporated in 1995 and is based in Lagos,...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 650
• Stock Exchange: Nigerian Stock Exchange
• Ticker Symbol: FIDSON

Financial Performance

In 2023, Fidson Healthcare's revenue was 53.05 billion, an increase of 30.56% compared to the previous year's 40.63 billion. Earnings were 3.61 billion, a decrease of -13.84%.